Although mix-ups appear to be rare, these errors in vaccine administration can have serious consequences to patients, including lack of proper protection from a disease, the need to revaccinate, diminished trust in vaccines, and increased healthcare costs.
Quality should be built into the entire drug product lifecycle – including the manufacturing and production process – to help protect patient safety and build trust in medicines. The same is true for compounded medicines.
The bipartisan support for the Pharmacy and Medically Underserved Areas Enhancement Act demonstrates that legislators and policymakers recognize the value pharmacists bring to patients and the U.S. healthcare system. USP applauds this step and supports swift passage of this important legislation.
Comment on USP's proposed Drug Classification System by December 5, 2016.
Learn about unique career paths in pharmacy. APhA CEO Thomas Menighan discusses his personal journey in pharmacy and provides insight into non-traditional roles for pharmacists highlighted in the new, free webinar series Careers Beyond the Pharmacy Counter.
New USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings provides consistent standards for the handling of hazardous drugs in healthcare settings to help minimize exposure to healthcare workers, avoid unintended and repeated exposures, and reduce the potential for adverse consequences.
October is Talk About Your Medicines Month. Sponsored by NCPIE, a USP Convention member organization, this annual opportunity encourages patients and healthcare providers to engage in conversation about medications and their safe use, safe storage, and safe disposal.
Pictograms, a free resource from USP, are simple illustrations that help ensure proper medication use for low-literacy and non-native language speaking patients. They provide healthcare professionals with a useful tool to overcome communication and comprehension issues that may arise.